Regulation & law · 21/02/2013Updated: 10/17/2026 · 1 min read
INB Hauser Pharmaceutical Services, Inc. Files Notice of Registration with the U.S. Drug Enforcement Administration for Controlled Substance Manufacturer
Summary
INB Hauser Pharmaceutical Services, Inc. has submitted a notice of registration to the U.S. Drug Enforcement Administration, indicating its intention to manufacture controlled substances, as required by law.
Original source language: Federal Register — Justice DepartmentOpen original release →